Journal article
Saudi Pharmaceutical Journal, vol. 33, Springer, 2025, p. 20
APA
Click to copy
Arshad, S., Maalik, A., Rehman, W., Khan, Y., Alanazi, M. M., Sarfraz, H., & Rasheed, L. (2025). Facile indazole-endowed thiadiazole hybrid derivatives as antibacterial, anti-diabetic and thymidine phosphorylase inhibitors: An insight to experimental, in-vitro biological potential and computational approaches. Saudi Pharmaceutical Journal, 33, 20.
Chicago/Turabian
Click to copy
Arshad, Sabeen, Aneela Maalik, Wajid Rehman, Yousaf Khan, Mohammed M Alanazi, Hina Sarfraz, and Liaqat Rasheed. “Facile Indazole-Endowed Thiadiazole Hybrid Derivatives as Antibacterial, Anti-Diabetic and Thymidine Phosphorylase Inhibitors: An Insight to Experimental, in-Vitro Biological Potential and Computational Approaches.” Saudi Pharmaceutical Journal 33 (2025): 20.
MLA
Click to copy
Arshad, Sabeen, et al. “Facile Indazole-Endowed Thiadiazole Hybrid Derivatives as Antibacterial, Anti-Diabetic and Thymidine Phosphorylase Inhibitors: An Insight to Experimental, in-Vitro Biological Potential and Computational Approaches.” Saudi Pharmaceutical Journal, vol. 33, Springer, 2025, p. 20.
BibTeX Click to copy
@article{arshad2025a,
title = {Facile indazole-endowed thiadiazole hybrid derivatives as antibacterial, anti-diabetic and thymidine phosphorylase inhibitors: An insight to experimental, in-vitro biological potential and computational approaches},
year = {2025},
journal = {Saudi Pharmaceutical Journal},
pages = {20},
publisher = {Springer},
volume = {33},
author = {Arshad, Sabeen and Maalik, Aneela and Rehman, Wajid and Khan, Yousaf and Alanazi, Mohammed M and Sarfraz, Hina and Rasheed, Liaqat}
}